Journal article
Mild orotic aciduria in UMPS heterozygotes: a metabolic finding without clinical consequences
SB Wortmann, MA Chen, R Colombo, A Pontoglio, B Alhaddad, LD Botto, T Yuzyuk, CR Coughlin, M Descartes, S Grűnewald, B Maranda, PB Mills, J Pitt, C Potente, R Rodenburg, LAJ Kluijtmans, S Sampath, EF Pai, RA Wevers, GE Tiller Show all
Journal of Inherited Metabolic Disease | Published : 2017
Open access
Abstract
Background: Elevated urinary excretion of orotic acid is associated with treatable disorders of the urea cycle and pyrimidine metabolism. Establishing the correct and timely diagnosis in a patient with orotic aciduria is key to effective treatment. Uridine monophosphate synthase is involved in de novo pyrimidine synthesis. Uridine monophosphate synthase deficiency (or hereditary orotic aciduria), due to biallelic mutations in UMPS, is a rare condition presenting with megaloblastic anemia in the first months of life. If not treated with the pyrimidine precursor uridine, neutropenia, failure to thrive, growth retardation, developmental delay, and intellectual disability may ensue. Methods and ..
View full abstractGrants
Awarded by Regione Lombardia (Italy)
Funding Acknowledgements
Part of this study was supported in part by Regione Lombardia (Italy), Innovative Research Project 1137-2010 (grant to Niguarda Ca' Granda Metropolitan Hospital).